☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
PharmaShots Weekly Snapshot (October 08 -12, 2018)
Share this
Senior Editor
Oct 15, 2018
Weekly Snapshot
PharmaShots Weekly Snapshot (October 08 -12, 2018)
Lilly and Metastatic Breast Cancer Advocates Reports RWE and Launches 'Thriver Movement #MoreforMBC
Published: 10 Oct, 2018 | Tags: Lilly; Metastatic Breast Cancer Advocates, Reports, RWE, Launches, Thriver Movement, #MoreforMBC
Sandoz Signs a Non-Exclusive License Agreement with AbbVie for IPR of its Humira (adalimumab) for Major EU Countries
Published: 11 Oct, 2018 |Tags: Sandoz, Signs, Non-Exclusive License, Agreement, AbbVie, IPR, Humira (adalimumab), EU Countries
Myriad and Pfizer Signs a Service Agreement for Testing of BRCA-Mutated Triple Negative Breast Cancer
Published: 10 Oct, 2018 | Tags: Myriad, Pfizer, Signs, Service Agreement, Testing, BRCA-Mutated Triple Negative Breast Cancer, Talazoparib
MundiPharama Acquires Cinfa Biotech for Expansion of its Biosimilar Portfolio
Published: 10 Oct, 2018 | Tags: Mundipharma, Acquires, Cinfa Biotech, Expansion, Biosimilar, Portfolio, Pelmeg, pegfilgrastim
Celgene to Present Results of Two P-III Trial SUNBEAM and RADIANCE Part B for Ozanimod to Treat RMS at ECTRIMS 2018
Published: 10 Oct, 2018 | Tags: Celgene, Present, Results, Two P-III Trial, SUNBEAM, RADIANCE Part B, Ozanimod, Treat, RMS, ECTRIMS 2018
K
onan Medical Receives FDA 510(k) Approval for its objectiveFIELD Device
Published: 10 Oct, 2018 | Tags: Konan Medical, Receives, FDA 510(k), Approval, objectiveFIELD Device, (mfPOP) Technology
Roche and Ionis Collaborates to Develop Ioniss IONIS-FB-LRx to Treat Complement-Mediated Diseases for $760M
Published: 10 Oct, 2018 | Tags: Roche, Ionis, Collaborates, Develop, IONIS-FB-LRx,Treat, Complement-Mediated Diseases, $760M
Celltrion and Teva Announces Approval Recommendations for CT-P10s (rituximab, biosimilar) BLA from the US FDAs ODAC
Published: 10 Oct, 2018 | Tags: Celltrion, Teva, Announces, Approval, Recommendations, CT-P10s (rituximab, biosimilar), BLA the US FDAs ODAC
Novartis Reports Results of P-IIIb ASSESS study for Gilenya (fingolimod) vs Copaxone (glatiramer acetate)
Published: 10 Oct, 2018 | Tags: Novartis, Reports, Results , P-IIIb, ASSESS study, Gilenya (fingolimod) , Copaxone (glatiramer acetate)
Eli Lily and Boehringer Ingelheims (BI) Jardiance (empagliflozin) Shows to Increase Life Span in Adults with T2D and Cardiovascular Disorders
Published: 10 Oct, 2018 | Tags: Eli Lily, Boehringer Ingelheim, Jardiance (empagliflozin), Shows, Increment, Life Span, Adults, T2D, Cardiovascular Disorders, EMPA-REG OUTCOME
MeiraGTx Acquires Vector Neurosciences to Strengthen its Neurology Portfolio
Published: 9 Oct, 2018 | Tags: MeiraGTx, Acquisition, Vector Neurosciences, Strengthen, Neurology Platform
Therachon Acquires GLyPharma Therapeutic to Expand its Rare Disease Portfolio
Published: 9 Oct, 2018 | Tags: Therachon, Acquires, GLyPharma, Therapeutic, Expand, Rare Disease Portfolio
Novartis Reports Positive Results of P-II SUSTAIN study for Crizanlizumab (SEG101) to Treat Sickle Cell Disease (SCD)
Published: 9 Oct, 2108 | Tags: Novartis, Reports, Results, P-II SUSTAIN study, Crizanlizumab (SEG101), Treatment, Sickle Cell Disease (SCD)
Roche to Present Results of P-III Trial for Ocrevus (ocrelizumab) at ECTRIMS 2018
Published: 10 Oct, 2108 | Tags: Roche, Present, Results, P-III Trial, Ocrevus (ocrelizumab), ECTRIMS 2018, OPERA I, OPERA II and ORATORIO
MVP and Daiichi Signs Exclusive Distribution and License Agreement for Penthrox in China, Thailand, Vietnam
Published: 8 Oct, 2108 | Tags: MVP, Daiichi, Signs, Exclusive, Distribution, License Agreement, Penthrox, China, Thailand, Vietnam
Roche to Present Positive Results of Cancer Immunotherapy Programmes at ESCO 2018
Published: 9 Oct, 2018 | Tags: Roche, Present, Positive Results, Cancer, Immunotherapy Programmes, ESCO 2018, P-III ALESIA, P-III IMpower130 study
Celgene Reports Otezla (apremilast) Achieve 1EP in P-III STYLE study to Treat Moderate-to-Severe Scalp Psoriasis
Published: 8 Oct, 2108 | Tags: Celgene, Reports, Otezla (apremilast), Achieve, 1EP, P-III STYLE study, Treat, Moderate-to-Severe Scalp Psoriasis
Regeneron to Present Results of Libtayo (cemiplimab) for Six Tumor Indications at ESMO 2018
Published: 8 Oct, 2108 | Tags: Regeneron, Present, Results, Libtayo (cemiplimab), Six, Tumor Indications, ESMO 2018, CSCC, mCSCC, the US FDA
Mercks Gardasil 9 Receives FDAs Expanded Label Approval for Prevention of HPV Related Disorders
Published: 5 Oct, 2018 | Tags: Merck, Gardasil 9, Receives, FDA, Expanded Label Approval, Prevention, HPV Related Disorders
AbbVies Orilissa (elagolix) Receives Health Canada Approval to Treat Moderate-to-Severe Pain Associated with Endometriosis
Published: 5 Oct, 2018 | Tags: AbbVie, Orilissa (elagolix), Receives, Health Canada, Approval, Moderate-to-Severe Pain, Endometriosis, P-III study
Novartis Announces Acceptance of its Novel Siponimod (BAF312) by the US FDA and EMA
Published: 8 Oct, 2018 | Tags: Novartis, Announces, Acceptance, Novel, Siponimod (BAF312) , the US FDA ,EMA ,NDA, MAA, Regulatory
Comments
Fill this Details
×
Name
Email
Company Name
Thank you for download PDF
Submit
Related News/Articles
PharmaShots Weekly Snapshots (November 04 – November 08, 2024)
November 8, 2024
PharmaShots Weekly Snapshots (October 28 – October 30, 2024)
November 1, 2024
PharmaShots Weekly Snapshots (October 21 – October 25, 2024)
October 25, 2024
PharmaShots Weekly Snapshots (October 14 – October 18, 2024)
October 18, 2024
PharmaShots Weekly Snapshots (October 07 – October 11, 2024)
October 11, 2024
PharmaShots Weekly Snapshots (September 30 – October 04, 2024)
October 4, 2024
PharmaShots Weekly Snapshots (September 30 – October 04, 2024)
October 4, 2024
PharmaShots Weekly Snapshots (September 23 – September 27, 2024)
September 27, 2024
PharmaShots Weekly Snapshots (September 16 – September 20, 2024)
September 20, 2024
PharmaShots Weekly Snapshots (September 09 – September 13, 2024)
September 13, 2024
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
×
Email
First Name
Last Name
Company Name
Area/Designation
Daily Newsletter
Weekly Newsletter
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions
X
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
Subscribe
Modal title
×
Modal body text goes here.